newsfilter
← Latest News
PR Newswire·

Cumberland Pharmaceuticals Reports 11.6% Fourth Quarter 2024 Revenue Growth

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved brands ...